OBJECTIVES: Therapeutic hypothermia (32-34 degrees C) is recommended for comatose survivors of cardiac arrest; however, the optimal technique for cooling is unknown. We aimed to compare therapeutic hypothermia using either surface or endovascular techniques in terms of efficacy, complications and outcome. DESIGN: Retrospective cohort study. SETTING: Thirty-bed teaching hospital intensive care unit (ICU). PATIENTS: All patients (n=83) undergoing therapeutic hypothermia following cardiac arrest over a 2.5-year period. The mean age was 61+/-16 years; 88% of arrests occurred out of hospital, and 64% were ventricular fibrillation/tachycardia. INTERVENTIONS: Therapeutic hypothermia was initiated in the ICU using iced Hartmann's solution, followed by either surface (n=41) or endovascular (n=42) cooling; choice of technique was based upon endovascular device availability. The target temperature was 32-34 degrees C for 12-24 h, followed by rewarming at a rate of 0.25 degrees Ch(-1). MEASUREMENTS AND MAIN RESULTS: Endovascular cooling provided a longer time within the target temperature range (p=0.02), less temperature fluctuation (p=0.003), better control during rewarming (0.04), and a lower 48-h temperature load (p=0.008). Endovascular cooling also produced less cooling-associated complications in terms of both overcooling (p=0.05) and failure to reach the target temperature (p=0.04). After adjustment for known confounders, there were no differences in outcome between the groups in terms of ICU or hospital mortality, ventilator free days and neurological outcome. CONCLUSION: Endovascular cooling provides better temperature management than surface cooling, as well as a more favorable complication profile. The equivalence in outcome suggested by this small study requires confirmation in a randomized trial. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
OBJECTIVES: Therapeutic hypothermia (32-34 degrees C) is recommended for comatose survivors of cardiac arrest; however, the optimal technique for cooling is unknown. We aimed to compare therapeutic hypothermia using either surface or endovascular techniques in terms of efficacy, complications and outcome. DESIGN: Retrospective cohort study. SETTING: Thirty-bed teaching hospital intensive care unit (ICU). PATIENTS: All patients (n=83) undergoing therapeutic hypothermia following cardiac arrest over a 2.5-year period. The mean age was 61+/-16 years; 88% of arrests occurred out of hospital, and 64% were ventricular fibrillation/tachycardia. INTERVENTIONS: Therapeutic hypothermia was initiated in the ICU using iced Hartmann's solution, followed by either surface (n=41) or endovascular (n=42) cooling; choice of technique was based upon endovascular device availability. The target temperature was 32-34 degrees C for 12-24 h, followed by rewarming at a rate of 0.25 degrees Ch(-1). MEASUREMENTS AND MAIN RESULTS: Endovascular cooling provided a longer time within the target temperature range (p=0.02), less temperature fluctuation (p=0.003), better control during rewarming (0.04), and a lower 48-h temperature load (p=0.008). Endovascular cooling also produced less cooling-associated complications in terms of both overcooling (p=0.05) and failure to reach the target temperature (p=0.04). After adjustment for known confounders, there were no differences in outcome between the groups in terms of ICU or hospital mortality, ventilator free days and neurological outcome. CONCLUSION: Endovascular cooling provides better temperature management than surface cooling, as well as a more favorable complication profile. The equivalence in outcome suggested by this small study requires confirmation in a randomized trial. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
Authors: Salam Jarrah; John Dziodzio; Christine Lord; Gilles L Fraser; Lee Lucas; Richard R Riker; David B Seder Journal: Neurocrit Care Date: 2011-06 Impact factor: 3.210
Authors: Anna Finley Caulfield; Shylaja Rachabattula; Irina Eyngorn; Scott A Hamilton; Rajalakshmi Kalimuthu; Amie W Hsia; Maarten G Lansberg; Chitra Venkatasubramanian; J J Baumann; Marion S Buckwalter; Monisha A Kumar; James S Castle; Christine A C Wijman Journal: Stroke Res Treat Date: 2011-07-25